Rabindra Tirouvanziam

Rabindra Tirouvanziam earned his Bioengineering degree at Agro Paris Tech (France) and his PhD in developmental biology, lung physiology and immunology at the College de France and National Centre for Scientific Research (Paris, France). He trained as a postdoctoral researcher in genetics at Stanford University (CA, USA) before joining Emory University as faculty. Research in his group include patient- and model-based studies in cystic fibrosis, flu, COVID-19, TB, and malaria, focusing on immunology and metabolism. The Tirouvanziam lab emphasizes sample collection from patients and optimized in vitro and animal models combined with high-content analyses by cytometry and transcriptomics (for cells) and multiplexed ELISA and mass spectrometry (for fluids) to delineate mechanisms of immunometabolism and their relations to chronic disease. The Tirouvanziam lab has received support from NIH, NSF, DARPA, and the CF Foundation. As of October 2022, Dr. Tirouvanziam counts over 80 papers, 150 abstracts and 5 patents.